Infectious Bovine Rhinotracheitis Vaccine, Inactivated (Strain C1)
Product Features
1. Chinese Virus Strain Adopted
The Strain BoHv-1/C1 of Infectious Bovine Rhinotracheitis is an epidemic strain in China, which has good protective effect on the epidemic strain in China, reduces the incidence of bovine infectious rhinotracheitis virus and other respiratory diseases, and improves the economic benefit of cattle farms.
2. Advanced Production Technology
The automated bioreactor cell culture technology is characteristic of high virus expression, stability and unity. The international advanced purification and concentration technology for the virus antigen is adopted to better maintain the antigenicity and immunogenicity. The content of endotoxin less than 1EU, providing good vaccine protective effect and slight side effects. Hence, high efficacy and safety of the vaccine can be achieved.
Vaccination Suggestions
(1) Negative cattle can be vaccinated as early as possible to prevent infection.
(2) Infected cattle can be vaccinated to effectively reduce the dosage of detoxification and lower the infection rate, and decrease the clinical incidence.
(3) The vaccine should be warmed to 25 ° C before immunization.
Immunization Procedure
(1) First Immunized Calves: the calves given birth by non-immunized cows should be vaccinated once at 30 days of age, further vaccinated once after an interval of 21 to 30 days at a dosage of 2ml/animal through intramuscular injection.
(2) Cattle for Rearing: the whole herd should get vaccinated once, and further vaccinated once after an interval of 1 month at a dosage of 2ml/animal through intramuscular injection.
(3) Immunized Cattle: vaccinated once at an interval of 4 to 6 months at a dosage of 2ml/animal through intramuscular injection.
(4) Pregnant Cows: use with caution 1.5 to 2 months before delivery.
(5) Calves Given Birth by Immunized Cows: vaccinated once at 3 months old, further vaccinated once after an interval of one month, and then vaccinated once after an interval of 4 to 6 months, at a dosage of 2ml/animal through intramuscular injection.